Design, Characterization, and 3D Printing of Cardiovascular Stents with Zero Poisson’s Ratio in Longitudinal Deformation

Abstract

Inherent drawbacks associated with drug-eluting stents have prompted the development of bioresorbable cardiovascular stents. Additive manufacturing (3-dimentional (3D) printing) has been widely applied in medical devices. In this study, we develop a novel screw extrusion-based 3D printing system with a new designed mini-screw extruder to fabricate stents. A stent with a zero Poisson's ratio (ZPR) structure is designed, and a preliminary monofilament test is conducted to investigate appropriate fabrication parameters. 3D-printed stents with different geometric structures are fabricated and analyzed by observation of the surface morphology. An evaluation of the mechanical properties and a preliminary biological evaluation of 3D-printed stents with different parameters are carried out. In conclusion, the screw extrusion-based 3D printing system shows potential for customizable stent fabrication.

Keywords

Additive manufacturing / 3D printing / Screw extrusion / Cardiovascular stent / Zero Poisson’s ratio

References

[[1]] Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937–48.

[[2]] Zhang Y, Bourantas CV, Farooq V, Muramatsu T, Diletti R, Onuma Y, et al. Bioresorbable scaffolds in the treatment of coronary artery disease. Med Devices Evid Res 2013;6:37–48.

[[3]] Wiebe J, Nef HM, Hamm CW. Current status of bioresorbable scaffolds in the treatment of coronary artery disease. J Am Coll Cardiol 2014;64:2541–51.

[[4]] Ang HY, Bulluck H, Wong P, Venkatraman SS, Huang Y, Foin N. Bioresorbable stents: current and upcoming bioresorbable technologies. Int J Cardiol 2017;228:931–9.

[[5]] Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193–202.

[[6]] Onuma Y, Ormiston J, Serruys PW. Bioresorbable scaffold technologies. Circ J 2011;75:509–20.

[[7]] Iqbal J, Onuma Y, Ormiston J, Abizaid A, Waksman R, Serruys P. Bioresorbable scaffolds: rationale, current status, challenges, and future. Eur Heart J 2014;35:765–76.

[[8]] Stepak B, Anton´ czak AJ, Bartkowiak-Jowsa M, Filipiak J, Pezowicz C, Abramski KM. Fabrication of a polymer-based biodegradable stent using a CO2 laser. Arch Civ Mech Eng 2014;14:317–26.

[[9]] Guerra AJ, Farjas J, Ciurana J. Fibre laser cutting of polycaprolactone sheet for stents manufacturing: a feasibility study. Opt Laser Technol 2017;95:113–23.

[[10]] Guerra AJ, Ciurana J. 3D-printed bioabsordable polycaprolactone stent: the effect of process parameters on its physical features. Mater Des 2018;137:430–7.

[[11]] Martinez AW, Chaikof EL. Microfabrication and nanotechnology in stent design. WIREs Nanomed Nanobiotechnol 2011;3:256–68.

[[12]] Kaesemeyer WH, Sprankle KG, Kremsky JN, Lau W, Helmus MN, Ghatnekar GS. Bioresorbable polystatin fourth-generation stents. Coron Artery Dis 2013;24:516–21.

[[13]] Park SA, Lee SJ, Lim KS, Bae IH, Lee JH, Kim WD, et al. In vivo evaluation and characterization of a bio-absorbable drug-coated stent fabricated using a 3Dprinting system. Mater Lett 2015;141:355–8.

[[14]] Wu Z, Zhao J, Wu W, Wang P, Wang B, Li G, et al. Radial compressive property and the proof-of-concept study for realizing self-expansion of 3D printing polylactic acid vascular stents with negative poisson’s ratio structure. Materials 2018;11(8):1357.

[[15]] Wang WQ, Liang DK, Yang DZ, Qi M. Analysis of the transient expansion behavior and design optimization of coronary stents by finite element method. J Biomech 2006;39:21–32.

[[16]] Stoeckel D, Bonsignore C, Duda S. A survey of stent designs. Minim Invasive Ther Allied Technol 2002;11:137–47.

[[17]] Attard D, Grima JN. Modelling of hexagonal honeycombs exhibiting zero Poisson’s ratio. Phys Status Solidi Basic Res 2011;248:52–9.

[[18]] Masters IG, Evans KE. Models for the elastic deformation of honeycombs. Compos Struct 1996;35:403–22.

[[19]] Young WC, Budynas RG. Roark’s formulas for stress and strain. 7th ed. Beijing: Tsinghua University Press; 2003. Chinese.

[[20]] Grima JN, Oliveri L, Attard D, Ellul B, Gatt R, Cicala G, et al. Hexagonal honeycombs with zero Poisson’s ratios and enhanced stiffness. Adv Eng Mater 2010;12:855–62.

[[21]] Venkataraman N, Rangarajan S, Matthewson MJ, Harper B, Safari A, Danforth SC, et al. Feedstock material property—process relationships in fused deposition of ceramics (FDC). Rapid Prototyp J 2000;6:244–52.

[[22]] Liu B, Xie Y, Wu M. Research on the micro-extrusion characteristic of mini-screw in the screw extruding spray head. Polym Bull 2010;64: 727–38.

[[23]] Wang F, Shor L, Darling A, Khalil S, Sun W, Güçeri S, et al. Precision extruding deposition and characterization of cellular poly-e-caprolactone tissue scaffolds. Rapid Prototyp J 2004;10:42–9.

[[24]] Capone C, Di Landro L, Inzoli F, Penco M, Sartore L. Thermal and mechanical degradation during polymer extrusion processing. Polym Eng Sci 2007;47:1813–9.

[[25]] Liu C, Li Y, Zhang L, Mi S, Xu Y, Sun W. Development of a novel lowtemperature deposition machine using screw extrusion to fabricate poly(Llactide-co-glycolide) acid scaffolds. Proc Inst Mech Eng Part H J Eng Med 2014;228:593–606.

[[26]] F2606-08 Standard guide for three-point bending of balloon expandable vascular stents and stent systems. US Standard. West Conshohocken: American Society of Testing Materials; 2014.

[[27]] F3067-14 Guide for radial loading of balloon expandable and self expanding vascular stents. US Standard. West Conshohocken: American Society of Testing Materials; 2014.

[[28]] Wang Q, Fang G, Zhao Y, Wang G, Cai T. Computational and experimental investigation into mechanical performances of poly-L-lactide acid (PLLA) coronary stents. J Mech Behav Biomed Mater 2017;65:415–27.

[[29]] Schmidt W, Behrens P, Brandt-Wunderlich C, Siewert S, Grabow N, Schmitz KP. In vitro performance investigation of bioresorbable scaffolds—standard tests for vascular stents and beyond. Cardiovasc Revascularization Med 2016;17:375–83.

[[30]] Schmidt W, Lanzer P, Behrens P, Topoleski LDT, Schmitz KP. A comparison of the mechanical performance characteristics of seven drug-eluting stent systems. Catheter Cardiovasc Interv 2009;73:350–60.

[[31]] Colombo A, Stankovic G, Moses JW. Selection of coronary stents. J Am Coll Cardiol 2002;40:1021–33.

[[32]] F756-17 Standard practice for assessment of hemolytic properties of materials. US Standard. West Conshohocken: American Society of Testing Materials; 2017.

[[33]] Im SH, Kim CY, Jung Y, Jang Y, Kim SH. Biodegradable vascular stents with high tensile and compressive strength: a novel strategy for applying monofilaments via solid-state drawing and shaped-annealing processes. Biomater Sci 2017;5:422–31.

[[34]] ISO 10993-5:2009 Biological evaluation of medical devices—part 5: tests for in vitro cytotoxicity. EN Standard. Geneva: International Organization for Standardization; 2009.